Growth Metrics

Vericel (VCEL) Long-Term Investments (2019 - 2026)

Vericel recorded quarterly Long-Term Investments of $101.3 million in Q1 2026, up 65.0% quarter-over-quarter from $61.4 million in Q4 2025, and up 22.34% year-over-year from $82.8 million in Q1 2025.

Vericel's Long-Term Investments history runs 8 years deep, the most recent figure standing at $101.3 million for Q1 2026.

  • In Q1 2026, Long-Term Investments rose 22.34% year-over-year to $101.3 million; the TTM figure through Mar 2026 stood at $101.3 million (up 22.34% YoY), while the FY2025 annual figure was $61.4 million, up 53.95% from the prior year.
  • Long-Term Investments came in at $101.3 million for Q1 2026 at Vericel, up from $61.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $101.3 million in Q1 2026 to a low of $20.0 million in Q4 2022.
  • A 5-year average of $52.1 million and a median of $49.7 million in 2025 frame the typical range for Long-Term Investments.
  • Across the five-year window, Long-Term Investments tumbled 70.03% in 2023 and surged 299.88% in 2024, its largest moves.
  • Vericel's Long-Term Investments stood at $20.0 million in 2022, then rose by 26.66% to $25.3 million in 2023, then surged by 57.73% to $39.9 million in 2024, then surged by 53.95% to $61.4 million in 2025, then soared by 65.0% to $101.3 million in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $101.3 million, $61.4 million, and $49.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 505,194.89
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 5.75 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 9.79 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 22.17 Mn
10 Vericel 1.69 Bn 1.55 Bn 49.27 Mn 101.30 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 101.30 Mn
Dec 31, 2025 61.40 Mn
Sep 30, 2025 49.66 Mn
Jun 30, 2025 47.40 Mn
Mar 31, 2025 82.80 Mn
Dec 31, 2024 39.88 Mn
Sep 30, 2024 80.90 Mn
Jun 30, 2024 26.12 Mn
Mar 31, 2024 29.43 Mn
Dec 31, 2023 25.28 Mn
Sep 30, 2023 20.23 Mn
Jun 30, 2023 20.99 Mn
Mar 31, 2023 77.40 Mn
Dec 31, 2022 19.96 Mn
Sep 30, 2022 67.50 Mn
Jun 30, 2022 68.40 Mn
Mar 31, 2022 67.70 Mn
Dec 31, 2021 25.69 Mn
Sep 30, 2021 20.24 Mn
Jun 30, 2021 24.83 Mn
Mar 31, 2021 51.40 Mn
Dec 31, 2020 24.10 Mn
Jun 30, 2020 25.10 Mn
Mar 31, 2020 37.70 Mn
Dec 31, 2019 9.25 Mn